C & F FINANCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that C & F FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $140.84M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $127.31M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $127.32M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $122.68M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $135.20M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $138.14M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $111.90M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $118.92M | Mar 3, 2021 |
| FY2019 | Dec 31, 2017 | $116.83M | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | $115.49M | Feb 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.84M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $19.83M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $23.60M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $29.16M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $28.67M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $22.12M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $4.37M | Mar 3, 2020 |
| FY2019 | Sep 30, 2019 | $4.88M | Mar 3, 2020 |
| FY2019 | Jun 30, 2019 | $5.84M | Mar 3, 2020 |
| FY2019 | Mar 31, 2019 | $3.77M | Mar 3, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.49M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $36.77M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $38.81M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $90.56M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $157.39M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($80.37M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($14.63M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $47.55M | Mar 3, 2021 |
| FY2019 | Dec 31, 2017 | $25.78M | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | $26.98M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $3.49M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $1.46M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $3.39M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $4.79M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $10.23M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $2.71M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $3.37M | Mar 3, 2021 |
| FY2019 | Dec 31, 2017 | $4.18M | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | $2.71M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.77B | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.56B | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $2.44B | Feb 27, 2025 |
| FY2024 | Dec 31, 2022 | $2.33B | Feb 27, 2025 |
| FY2022 | Dec 31, 2021 | $2.26B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.09B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.66B | Mar 3, 2021 |
| FY2020 | Dec 31, 2018 | $1.52B | Mar 3, 2021 |
| FY2019 | Dec 31, 2017 | $1.51B | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | $1.45B | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.51B | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.34B | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $2.22B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.14B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.05B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.89B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Mar 3, 2021 |
| FY2019 | Dec 31, 2018 | $1.37B | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $1.37B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1.31B | Mar 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $261.75M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $226.36M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $216.88M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $195.63M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $210.32M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $193.81M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $164.80M | Mar 3, 2021 |
| FY2019 | Dec 31, 2018 | $151.96M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $141.70M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $139.21M | Feb 26, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.19M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $25.19M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $25.19M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $25.19M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $25.19M | Feb 28, 2023 |
| FY2022 | Dec 31, 2020 | $25.19M | Feb 28, 2023 |
| FY2022 | Dec 31, 2019 | $14.43M | Feb 28, 2023 |
| FY2019 | Dec 31, 2018 | $14.43M | Mar 3, 2020 |
| FY2019 | Dec 31, 2017 | $14.43M | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | $14.43M | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $268.70M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $247.81M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $233.76M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $217.21M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $193.81M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $170.82M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $154.25M | Mar 3, 2021 |
| FY2019 | Dec 31, 2018 | $140.52M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $127.43M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $125.16M | Mar 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $148.14M | Mar 7, 2014 |
| FY2013 | Dec 31, 2012 | $25.62M | Mar 7, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $132.99M | Mar 7, 2014 |
| FY2013 | Dec 31, 2012 | $132.99M | Mar 7, 2014 |
| FY2012 | Dec 31, 2011 | $132.99M | Mar 5, 2013 |
| FY2011 | Dec 31, 2010 | $132.90M | Mar 5, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 6 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 5 | Mar 1, 2022 |
| FY2019 | Dec 31, 2018 | 5 | Mar 3, 2020 |
| FY2019 | Dec 31, 2017 | 1 | Mar 3, 2020 |
| FY2018 | Dec 31, 2016 | 3 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 6 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 5 | Mar 1, 2022 |
| FY2018 | Dec 31, 2018 | 1 | Feb 26, 2019 |
| FY2018 | Sep 30, 2018 | 1 | Feb 26, 2019 |
| FY2018 | Jun 30, 2018 | 1 | Feb 26, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.25M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | 3.23M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | 3.37M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 3.48M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 3.55M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 3.67M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 3.44M | Mar 3, 2021 |
| FY2019 | Dec 31, 2018 | 3.50M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | 3.50M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 3.47M | Mar 8, 2018 |